LA County/USC Medical Center

Los Angeles, California 90033

0 studies enrolling now · 20 studies all time

What they study most

Acute Kidney Injury, Chronic Heart Failure, Erosive Esophagitis, Gastrointestinal Hemorrhage, HIV Infections, Obscure Gastrointestinal Bleeding (Occult or Overt), Peptic Ulcer Hemorrhage, Pulmonary Tuberculosis, Sepsis, Septic Shock, Severe Sepsis, Traumatic Brain Injury (TBI)

Studies at this site

• TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment — Completed
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection — Completed
• Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis — Completed
• Time Interval for Endoscopic Variceal Ligation — Completed
• Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU — Completed
• Protocolized Care for Early Septic Shock — Completed
• Noninvasive Monitoring of Cerebral Blood Flow Autoregulation in Patients With Traumatic Brain Injury (TBI) — Withdrawn before enrolling
• Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure — Completed
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz — Completed
• TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance — Completed
• TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment — Completed
• Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers — Completed
• Trial of Wireless Capsule Endoscopy in the Evaluation of Obscure Gastrointestinal Bleeding — Completed
• Early Colonoscopy for Lower Gastrointestinal (GI) Bleeding — Stopped early
• TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB — Completed
• TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine — Completed
• TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis — Completed
• TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis — Completed
• TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen — Completed
• TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB — Completed